Sitilo Experience on Peritoneal Carcinomatosis from Colorectal Cancer: Clinical Prognostic Features

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 4 SUPPL., 2003, Pages 29-33

  Cavaliere, Francesco ^a   Perri, P ^a   Rossi, C R ^b   Pilati, P L ^b   De Simone, M ^c   Vaira, M ^c   Deraco, M ^d   Aloe, S ^a   Di Filippo, S ^a   Di Filippo, F ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c SAN GIUSEPPE HOSPITAL   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Hyperthermic chemoperfusion; Peritoneal carcinomatosis; Peritonectomy

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ADULT; AGED; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL SURGERY; CONFERENCE PAPER; HUMAN; HYPERTHERMIC THERAPY; INTRAOPERATIVE PERIOD; ITALY; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTICENTER STUDY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TISSUE PERFUSION; TREATMENT INDICATION;

ADULT; AGED; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DISEASE-FREE SURVIVAL; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; MITOMYCIN; PERITONEAL NEOPLASMS; PROGNOSIS; SOCIETIES, MEDICAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 12144289382     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Sadeghi B., Arvieux C., Glehen O., et al: Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88: 358-363, 2000.
2. Jayne D.G., Fook S., Loi C., et al: Peritoneal carcinomatosis from colorectal cancer. Br. J. Surg. 89: 1545-1550, 2002.
3. Saltz L.B., Cox J.V., Blande C., et al: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N.E.J.M.343(13): 905-914, 2000.
4. Shen P., Levine E.A., Hall J., et al: Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch. Surg. 138: 26-33, 2003.
5. Pestieau S.R., Sugarbaker P.H.: Treatment of primary colon cancer with peritoneal carcinomatosis. Dis. Colon Rectum 43(10): 1341-1348, 2000.
6. Fujimura T., Yonemura Y., Fujita H., et al: Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies. Int. Surg. 84: 60-66, 1999.
7. Elias D., Pocard M.: Treatment and prevention of peritoneal carcinomatosis from colorectal cancer. Surg. Clin. North Am. 12: 542-559, 2003.
8. Cavaliere F., Di Filippo F., Cosimelli M., et al: The surgical treatment of peritoneal carcinomatosis. J. Exp. Clin. Cancer Res. 16: 105-107, 1997.
9. Zoetmulder F.A.N., Verwaal V., Ruth S., et al: Hyperthermic intra peritoneal chemotherapy (HIPEC) with mitomicin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin. Proceeding of A.S.C.O. vol 21, 586, 2002.
10. Sugarbaker P.H.: Peritonectomy procedures. Ann. Surg.; 221: 29-42, 1995.
11. Ozols R.F., Young R.C., Speyer J.L. et al: Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer. Cancer Res.; 42: 4265-9, 1982.
12. Nishimori H., Yasoshima T., Denno R., et al: A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: different mechanisms in peritoneal dissemination and hematogenous metastasis. Jpn. J. Cancer Res.; 91(7): 715-22, 2000.
13. Kanellos I., Demetriades H., Zintzaras E., Mandrali A., Mantzoros I., Betsis D.: Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis. Colon Rectum 46(4): 535-539, 2003.
14. Cavaliere F., Di Filippo F., Botti C., et al: Peritonectomy and hyperthermic-antiblastic perfusion in the treatment of peritoneal carcinomatosis. Eur. J. Surg. Oncol. 26: 486-491, 2000.
15. Sayag-Beaujard A., Francois Y., Glehen O., et al: Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C. Electronic Journal Oncology 1: 103-131, 1999.
16. Pilati P., Mocellin S., Rossi C.R., et al: Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann. Surg. Oncol. 10(5): 508-513, 2003.
17. Sugarbaker P.H., Schellinx M.E.T., Chang D., Koslowe P., von Meyerfeldt M.: Peritoneal carcinomatosis from adenocarcinoma of the colon. World J. Surg. 20: 585-592, 1996.
18. Pesteiau S.R., Sugarbaker P.H.: Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis. Colon Rectum 43: 1341-1346, 2000.
19. Shen P., Levine E.A., Hall J., et al: Predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch. Surg. 138: 26-33, 2003.